{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:05:22Z","timestamp":1789639522131,"version":"4.0.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T00:00:00Z","timestamp":1522195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s11894-018-0620-2","type":"journal-article","created":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T16:43:50Z","timestamp":1522255430000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["The IBD and PSC Phenotypes of PSC-IBD"],"prefix":"10.1007","volume":"20","author":[{"given":"Amanda","family":"Ricciuto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binita M.","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,28]]},"reference":[{"issue":"6","key":"620_CR1","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","volume":"67","author":"TH Karlsen","year":"2017","unstructured":"Karlsen TH, Folseraas T, Thorburn D, Vesterhus M. Primary sclerosing cholangitis\u2014a comprehensive review. J Hepatol. 2017;67(6):1298\u2013323. \n                      https:\/\/doi.org\/10.1016\/j.jhep.2017.07.022\n                      \n                    .","journal-title":"J Hepatol"},{"key":"620_CR2","doi-asserted-by":"publisher","first-page":"Cd011343","DOI":"10.1002\/14651858.CD011343.pub2","volume":"3","author":"F Saffioti","year":"2017","unstructured":"Saffioti F, Gurusamy KS, Hawkins N, Toon CD, Tsochatzis E, Davidson BR, et al. Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis. Cochrane Database Syst Rev. 2017;3:Cd011343. \n                      https:\/\/doi.org\/10.1002\/14651858.CD011343.pub2\n                      \n                    .","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"620_CR3","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1159\/000471874","volume":"35","author":"X Peng","year":"2017","unstructured":"Peng X, Luo X, Hou JY, Wu SY, Li LZ, Zheng MH, et al. Immunosuppressive agents for the treatment of primary sclerosing cholangitis: a systematic review and meta-analysis. Dig Dis (Basel, Switzerland). 2017;35(5):478\u201385. \n                      https:\/\/doi.org\/10.1159\/000471874\n                      \n                    .","journal-title":"Dig Dis (Basel, Switzerland)"},{"issue":"12","key":"620_CR4","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1056\/NEJMra1506330","volume":"375","author":"KN Lazaridis","year":"2016","unstructured":"Lazaridis KN, LaRusso NF. Primary sclerosing cholangitis. N Engl J Med. 2016;375(12):1161\u201370. \n                      https:\/\/doi.org\/10.1056\/NEJMra1506330\n                      \n                    .","journal-title":"N Engl J Med"},{"issue":"4","key":"620_CR5","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1053\/j.gastro.2016.08.046","volume":"151","author":"RK Weersma","year":"2016","unstructured":"Weersma RK, Lindor KD. Shifting paradigms: what is the true prevalence and clinical course of primary sclerosing cholangitis? Gastroenterology. 2016;151(4):590\u20133. \n                      https:\/\/doi.org\/10.1053\/j.gastro.2016.08.046\n                      \n                    .","journal-title":"Gastroenterology"},{"issue":"1","key":"620_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0002-9610(66)90339-4","volume":"111","author":"KW Warren","year":"1966","unstructured":"Warren KW, Athanassiades S, Monge JI. Primary sclerosing cholangitis. A study of forty-two cases. Am J Surg. 1966;111(1):23\u201338.","journal-title":"Am J Surg"},{"issue":"10","key":"620_CR7","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1136\/gutjnl-2016-312137","volume":"65","author":"TH Karlsen","year":"2016","unstructured":"Karlsen TH. Primary sclerosing cholangitis: 50 years of a gut-liver relationship and still no love? Gut. 2016;65(10):1579\u201381. \n                      https:\/\/doi.org\/10.1136\/gutjnl-2016-312137\n                      \n                    .","journal-title":"Gut"},{"issue":"5","key":"620_CR8","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","volume":"56","author":"K Boonstra","year":"2012","unstructured":"Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol. 2012;56(5):1181\u20138. \n                      https:\/\/doi.org\/10.1016\/j.jhep.2011.10.025\n                      \n                    .","journal-title":"J Hepatol"},{"issue":"6","key":"620_CR9","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3748\/wjg.v21.i6.1956","volume":"21","author":"AB Vries de","year":"2015","unstructured":"\u2022\u2022 de Vries AB, Janse M, Blokzijl H, Weersma RK. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World J Gastroenterol: WJG. 2015;21(6):1956\u201371. \n                      https:\/\/doi.org\/10.3748\/wjg.v21.i6.1956\n                      \n                    . Systematic review of studies investigating the IBD phenotype of PSC-IBD in adults.","journal-title":"World J Gastroenterol: WJG"},{"key":"620_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jaut.2013.07.005","volume":"46","author":"A Tanaka","year":"2013","unstructured":"Tanaka A, Takikawa H. Geoepidemiology of primary sclerosing cholangitis: a critical review. J Autoimmun. 2013;46:35\u201340. \n                      https:\/\/doi.org\/10.1016\/j.jaut.2013.07.005\n                      \n                    .","journal-title":"J Autoimmun"},{"key":"620_CR11","doi-asserted-by":"publisher","unstructured":"Palmela C, Peerani F, Castaneda D, Torres J, Itzkowitz SH. Inflammatory bowel disease and primary sclerosing cholangitis: a review of the phenotype and associated specific features. Gut Liver. 2017 \n                      https:\/\/doi.org\/10.5009\/gnl16510\n                      \n                    .","DOI":"10.5009\/gnl16510"},{"issue":"5 Pt 1","key":"620_CR12","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/0016-5085(91)90784-I","volume":"100","author":"R Olsson","year":"1991","unstructured":"Olsson R, Danielsson A, Jarnerot G, Lindstrom E, Loof L, Rolny P, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology. 1991;100(5 Pt 1):1319\u201323.","journal-title":"Gastroenterology"},{"issue":"1","key":"620_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/MEG.0000000000000747","volume":"29","author":"M Fraga","year":"2017","unstructured":"Fraga M, Fournier N, Safroneeva E, Pittet V, Godat S, Straumann A, et al. Primary sclerosing cholangitis in the Swiss inflammatory bowel disease cohort study: prevalence, risk factors, and long-term follow-up. Eur J Gastroenterol Hepatol. 2017;29(1):91\u20137. \n                      https:\/\/doi.org\/10.1097\/meg.0000000000000747\n                      \n                    .","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"620_CR14","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1053\/j.gastro.2016.06.021","volume":"151","author":"AK Lunder","year":"2016","unstructured":"\u2022 Lunder AK, Hov JR, Borthne A, Gleditsch J, Johannesen G, Tveit K, et al. Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory bowel disease. Gastroenterology. 2016;151(4):660\u20139.e4. \n                      https:\/\/doi.org\/10.1053\/j.gastro.2016.06.021\n                      \n                    . Recent study in which MRCP screening of IBD patients revealed a higher than previously appreciated prevalence of PSC.","journal-title":"Gastroenterology"},{"issue":"6","key":"620_CR15","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/hep.26565","volume":"58","author":"K Boonstra","year":"2013","unstructured":"Boonstra K, Weersma RK, van Erpecum KJ, Rauws EA, Spanier BW, Poen AC, et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology (Baltimore, Md). 2013;58(6):2045\u201355. \n                      https:\/\/doi.org\/10.1002\/hep.26565\n                      \n                    .","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"1","key":"620_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3748\/wjg.v18.i1.1","volume":"18","author":"B Fosby","year":"2012","unstructured":"Fosby B, Karlsen TH, Recurrence ME. Rejection in liver transplantation for primary sclerosing cholangitis. World J Gastroenterol: WJG. 2012;18(1):1\u201315. \n                      https:\/\/doi.org\/10.3748\/wjg.v18.i1.1\n                      \n                    .","journal-title":"World J Gastroenterol: WJG"},{"issue":"10","key":"620_CR17","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1080\/17474124.2017.1343666","volume":"11","author":"K Liu","year":"2017","unstructured":"Liu K, Strasser SI, Koorey DJ, Leong RW, Solomon M, McCaughan GW. Interactions between primary sclerosing cholangitis and inflammatory bowel disease: implications in the adult liver transplant setting. Expert Rev Gastroenterol Hepatol. 2017;11(10):949\u201360. \n                      https:\/\/doi.org\/10.1080\/17474124.2017.1343666\n                      \n                    .","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"10","key":"620_CR18","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1080\/003655202760373434","volume":"37","author":"KM Boberg","year":"2002","unstructured":"Boberg KM, Bergquist A, Mitchell S, Pares A, Rosina F, Broome U, et al. Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol. 2002;37(10):1205\u201311.","journal-title":"Scand J Gastroenterol"},{"key":"620_CR19","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Weismuller TJ, Trivedi PJ, Bergquist A, Imam M, Lenzen H, Ponsioen CY, et al. Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis. Gastroenterology. 2017; \n                      https:\/\/doi.org\/10.1053\/j.gastro.2017.02.038\n                      \n                    . The largest clinical PSC study to date (>7000 patients). PSC-CD and no IBD were associated with better PSC outcomes than PSC-UC when analyzing IBD as a time-dependent covariate.","DOI":"10.1053\/j.gastro.2017.02.038"},{"issue":"5","key":"620_CR20","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1136\/gut.51.5.731","volume":"51","author":"E Bjornsson","year":"2002","unstructured":"Bjornsson E, Boberg KM, Cullen S, Fleming K, Clausen OP, Fausa O, et al. Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut. 2002;51(5):731\u20135.","journal-title":"Gut"},{"issue":"1","key":"620_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11894-009-0006-6","volume":"11","author":"E Bjornsson","year":"2009","unstructured":"Bjornsson E. Small-duct primary sclerosing cholangitis. Curr Gastroenterol Rep. 2009;11(1):37\u201341.","journal-title":"Curr Gastroenterol Rep"},{"issue":"4","key":"620_CR22","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/hep.26454","volume":"58","author":"M Deneau","year":"2013","unstructured":"\u2022 Deneau M, Jensen MK, Holmen J, Williams MS, Book LS, Guthery SL. Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history. Hepatology (Baltimore, Md). 2013;58(4):1392\u2013400. \n                      https:\/\/doi.org\/10.1002\/hep.26454\n                      \n                    . The largest clinical pediatric PSC study to date, providing natural history data on >700 children.","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"5","key":"620_CR23","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1111\/j.1572-0241.2007.01103.x","volume":"102","author":"GG Kaplan","year":"2007","unstructured":"Kaplan GG, Laupland KB, Butzner D, Urbanski SJ, Lee SS. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Am J Gastroenterol. 2007;102(5):1042\u20139. \n                      https:\/\/doi.org\/10.1111\/j.1572-0241.2007.01103.x\n                      \n                    .","journal-title":"Am J Gastroenterol"},{"key":"620_CR24","doi-asserted-by":"publisher","unstructured":"Deneau MR, El-Matary W, Valentino PL, Abdou R, Alqoaer K, Amin M, et al. The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration. Hepatology (Baltimore, Md). 2017; \n                      https:\/\/doi.org\/10.1002\/hep.29204\n                      \n                    .","DOI":"10.1002\/hep.29204"},{"issue":"10","key":"620_CR25","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1111\/jgh.13774","volume":"32","author":"JE Eaton","year":"2017","unstructured":"Eaton JE, McCauley BM, Atkinson EJ, Juran BD, Schlicht EM, de Andrade M, et al. Variations in primary sclerosing cholangitis across the age spectrum. J Gastroenterol Hepatol. 2017;32(10):1763\u20138. \n                      https:\/\/doi.org\/10.1111\/jgh.13774\n                      \n                    .","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"620_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/MPG.0000000000001078","volume":"63","author":"M Bramuzzo","year":"2016","unstructured":"\u2022 Bramuzzo M, Martelossi S, Torre G, Cardile S, Arrigo S, Vignola S, et al. Clinical features and risk factors of autoimmune liver involvement in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2016;63(2):259\u201364. \n                      https:\/\/doi.org\/10.1097\/mpg.0000000000001078\n                      \n                    . The largest study to date describing the IBD phenotype of PSC-IBD in children.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"620_CR27","doi-asserted-by":"publisher","first-page":"268","DOI":"10.5223\/pghn.2015.18.4.268","volume":"18","author":"J Yoon","year":"2015","unstructured":"Yoon J, Oh SH, Kim HJ, Park SH, Ye BD, Yang SK, et al. Primary sclerosing cholangitis with inflammatory bowel disease in Korean children. Pediatr Gastroenterol Hepatol Nutr. 2015;18(4):268\u201375. \n                      https:\/\/doi.org\/10.5223\/pghn.2015.18.4.268\n                      \n                    .","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"issue":"1","key":"620_CR28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1053\/jhep.2003.50289","volume":"38","author":"AE Feldstein","year":"2003","unstructured":"Feldstein AE, Perrault J, El-Youssif M, Lindor KD, Freese DK, Angulo P. Primary sclerosing cholangitis in children: a long-term follow-up study. Hepatology (Baltimore, Md). 2003;38(1):210\u20137. \n                      https:\/\/doi.org\/10.1053\/jhep.2003.50289\n                      \n                    .","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"2","key":"620_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.cgh.2008.10.019","volume":"7","author":"T Miloh","year":"2009","unstructured":"Miloh T, Arnon R, Shneider B, Suchy F, Kerkar NA. Retrospective single-center review of primary sclerosing cholangitis in children. Clin Gastroenterol Hepatol. 2009;7(2):239\u201345. \n                      https:\/\/doi.org\/10.1016\/j.cgh.2008.10.019\n                      \n                    .","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1, Supplement","key":"620_CR30","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1016\/S0168-8278(17)30414-2","volume":"66","author":"F Bazerbachi","year":"2017","unstructured":"Bazerbachi F, Furuya KN, Abdou R, Alqoaer K, Amin M, Amir A, et al. PS-138\u2014recurrence of primary sclerosing cholangitis after liver transplantation in children: data from the Pediatric PSC Consortium. J Hepatol. 2017;66(1, Supplement):S76. \n                      https:\/\/doi.org\/10.1016\/S0168-8278(17)30414-2\n                      \n                    .","journal-title":"J Hepatol"},{"key":"620_CR31","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nrgastro.2016.154","volume":"14","author":"X Jiang","year":"2017","unstructured":"Jiang X, Karlsen TH. Genetics of primary sclerosing cholangitis and pathophysiological implications. Nat Rev Gastroenterol Hepatol. 2017;14:279\u201395. \n                      https:\/\/doi.org\/10.1038\/nrgastro.2016.154\n                      \n                    .","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"620_CR32","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/hep.25977","volume":"58","author":"D Ellinghaus","year":"2013","unstructured":"Ellinghaus D, Folseraas T, Holm K, Ellinghaus E, Melum E, Balschun T, et al. Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4. Hepatology (Baltimore, Md). 2013;58(3):1074\u201383. \n                      https:\/\/doi.org\/10.1002\/hep.25977\n                      \n                    .","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"6","key":"620_CR33","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1002\/hep.24307","volume":"53","author":"M Janse","year":"2011","unstructured":"Janse M, Lamberts LE, Franke L, Raychaudhuri S, Ellinghaus E, Muri Boberg K, et al. Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9. Hepatology (Baltimore, Md). 2011;53(6):1977\u201385. \n                      https:\/\/doi.org\/10.1002\/hep.24307\n                      \n                    .","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"2","key":"620_CR34","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jhep.2012.03.031","volume":"57","author":"T Folseraas","year":"2012","unstructured":"Folseraas T, Melum E, Rausch P, Juran BD, Ellinghaus E, Shiryaev A, et al. Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci. J Hepatol. 2012;57(2):366\u201375. \n                      https:\/\/doi.org\/10.1016\/j.jhep.2012.03.031\n                      \n                    .","journal-title":"J Hepatol"},{"issue":"11","key":"620_CR35","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1084\/jem.20041035","volume":"200","author":"B Eksteen","year":"2004","unstructured":"Eksteen B, Grant AJ, Miles A, Curbishley SM, Lalor PF, Hubscher SG, et al. Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis. J Exp Med. 2004;200(11):1511\u20137. \n                      https:\/\/doi.org\/10.1084\/jem.20041035\n                      \n                    .","journal-title":"J Exp Med"},{"issue":"9301","key":"620_CR36","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S0140-6736(02)07374-9","volume":"359","author":"AJ Grant","year":"2002","unstructured":"Grant AJ, Lalor PF, Salmi M, Jalkanen S, Adams DH. Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease. Lancet. 2002;359(9301):150\u20137. \n                      https:\/\/doi.org\/10.1016\/s0140-6736(02)07374-9\n                      \n                    .","journal-title":"Lancet"},{"issue":"2","key":"620_CR37","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/ng.3745","volume":"49","author":"SG Ji","year":"2017","unstructured":"\u2022 Ji SG, Juran BD, Mucha S, Folseraas T, Jostins L, Melum E, et al. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease. Nat Genet. 2017;49(2):269\u201373. \n                      https:\/\/doi.org\/10.1038\/ng.3745\n                      \n                    . A genome-wide association study of PSC that showed relatively little genetic overlap between PSC and IBD.","journal-title":"Nat Genet"},{"issue":"11","key":"620_CR38","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1136\/gutjnl-2017-314249","volume":"66","author":"SP O'Hara","year":"2017","unstructured":"O'Hara SP, Karlsen TH, LaRusso NF. Cholangiocytes and the environment in primary sclerosing cholangitis: where is the link? Gut. 2017;66(11):1873\u20137. \n                      https:\/\/doi.org\/10.1136\/gutjnl-2017-314249\n                      \n                    .","journal-title":"Gut"},{"issue":"6","key":"620_CR39","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S1076-6332(05)80410-6","volume":"2","author":"SN Lichtman","year":"1995","unstructured":"Lichtman SN, Wang J, Clark RL. A microcholangiographic study of liver disease models in rats. Acad Radiol. 1995;2(6):515\u201321.","journal-title":"Acad Radiol"},{"issue":"2","key":"620_CR40","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/0016-5085(90)90833-M","volume":"98","author":"SN Lichtman","year":"1990","unstructured":"Lichtman SN, Sartor RB, Keku J, Schwab JH. Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth. Gastroenterology. 1990;98(2):414\u201323.","journal-title":"Gastroenterology"},{"issue":"10","key":"620_CR41","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1111\/j.1478-3231.2011.02635.x","volume":"31","author":"T Mueller","year":"2011","unstructured":"Mueller T, Beutler C, Pico AH, Shibolet O, Pratt DS, Pascher A, et al. Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis. Liver Int. 2011;31(10):1574\u201388. \n                      https:\/\/doi.org\/10.1111\/j.1478-3231.2011.02635.x\n                      \n                    .","journal-title":"Liver Int"},{"issue":"1","key":"620_CR42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/hep.27927","volume":"63","author":"JH Tabibian","year":"2016","unstructured":"Tabibian JH, O'Hara SP, Trussoni CE, Tietz PS, Splinter PL, Mounajjed T, et al. Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis. Hepatology (Baltimore, Md). 2016;63(1):185\u201396. \n                      https:\/\/doi.org\/10.1002\/hep.27927\n                      \n                    .","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"4","key":"620_CR43","doi-asserted-by":"publisher","first-page":"e13117","DOI":"10.14814\/phy2.13117","volume":"5","author":"E Schrumpf","year":"2017","unstructured":"Schrumpf E, Jiang X, Zeissig S, Pollheimer MJ, Anmarkrud JA, Tan C, et al. The role of natural killer T cells in a mouse model with spontaneous bile duct inflammation. Phys Rep. 2017;5(4):e13117. \n                      https:\/\/doi.org\/10.14814\/phy2.13117\n                      \n                    .","journal-title":"Phys Rep"},{"issue":"7","key":"620_CR44","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/apt.13552","volume":"43","author":"J Torres","year":"2016","unstructured":"Torres J, Bao X, Goel A, Colombel JF, Pekow J, Jabri B, et al. The features of mucosa-associated microbiota in primary sclerosing cholangitis. Aliment Pharmacol Ther. 2016;43(7):790\u2013801. \n                      https:\/\/doi.org\/10.1111\/apt.13552\n                      \n                    .","journal-title":"Aliment Pharmacol Ther"},{"key":"620_CR45","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","volume":"66","author":"M Kummen","year":"2016","unstructured":"Kummen M, Holm K, Anmarkrud JA, Nygard S, Vesterhus M, Hoivik ML, et al. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls. Gut. 2016;66:611\u20139. \n                      https:\/\/doi.org\/10.1136\/gutjnl-2015-310500\n                      \n                    .","journal-title":"Gut"},{"issue":"10","key":"620_CR46","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","volume":"65","author":"J Sabino","year":"2016","unstructured":"Sabino J, Vieira-Silva S, Machiels K, Joossens M, Falony G, Ballet V, et al. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD. Gut. 2016;65(10):1681\u20139. \n                      https:\/\/doi.org\/10.1136\/gutjnl-2015-311004\n                      \n                    .","journal-title":"Gut"},{"issue":"4","key":"620_CR47","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/ecco-jcc\/jju023","volume":"9","author":"NG Rossen","year":"2015","unstructured":"Rossen NG, Fuentes S, Boonstra K, D'Haens GR, Heilig HG, Zoetendal EG, et al. The mucosa-associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II. J Crohns Colitis. 2015;9(4):342\u20138. \n                      https:\/\/doi.org\/10.1093\/ecco-jcc\/jju023\n                      \n                    .","journal-title":"J Crohns Colitis"},{"issue":"2","key":"620_CR48","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1136\/gutjnl-2016-311915","volume":"66","author":"MN Quraishi","year":"2017","unstructured":"Quraishi MN, Sergeant M, Kay G, Iqbal T, Chan J, Constantinidou C, et al. The gut-adherent microbiota of PSC-IBD is distinct to that of IBD. Gut. 2017;66(2):386\u20138. \n                      https:\/\/doi.org\/10.1136\/gutjnl-2016-311915\n                      \n                    .","journal-title":"Gut"},{"issue":"3","key":"620_CR49","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/ecco-jcc\/jjv204","volume":"10","author":"D Kevans","year":"2016","unstructured":"Kevans D, Tyler AD, Holm K, Jorgensen KK, Vatn MH, Karlsen TH, et al. Characterization of intestinal microbiota in ulcerative colitis patients with and without primary sclerosing cholangitis. J Crohns Colitis. 2016;10(3):330\u20137. \n                      https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv204\n                      \n                    .","journal-title":"J Crohns Colitis"},{"issue":"4","key":"620_CR50","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1136\/gutjnl-2016-312180","volume":"66","author":"MC Ruhlemann","year":"2017","unstructured":"Ruhlemann MC, Heinsen FA, Zenouzi R, Lieb W, Franke A, Schramm C. Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis. Gut. 2017;66(4):753\u20134. \n                      https:\/\/doi.org\/10.1136\/gutjnl-2016-312180\n                      \n                    .","journal-title":"Gut"},{"issue":"25","key":"620_CR51","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.3748\/wjg.v23.i25.4548","volume":"23","author":"L Bajer","year":"2017","unstructured":"Bajer L, Kverka M, Kostovcik M, Macinga P, Dvorak J, Stehlikova Z, et al. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis. World J Gastroenterol: WJG. 2017;23(25):4548\u201358. \n                      https:\/\/doi.org\/10.3748\/wjg.v23.i25.4548\n                      \n                    .","journal-title":"World J Gastroenterol: WJG"},{"issue":"3","key":"620_CR52","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/hep.23082","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, et al. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology (Baltimore, Md). 2009;50(3):808\u201314. \n                      https:\/\/doi.org\/10.1002\/hep.23082\n                      \n                    .","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"3","key":"620_CR53","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/0016-5085(89)90903-7","volume":"96","author":"JR Cangemi","year":"1989","unstructured":"Cangemi JR, Wiesner RH, Beaver SJ, Ludwig J, MacCarty RL, Dozois RR, et al. Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis. Gastroenterology. 1989;96(3):790\u20134.","journal-title":"Gastroenterology"},{"issue":"12","key":"620_CR54","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/BF02049156","volume":"38","author":"U Broome","year":"1995","unstructured":"Broome U, Lofberg R, Lundqvist K, Veress B. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis. Dis Colon Rectum. 1995;38(12):1301\u20135.","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"620_CR55","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/BF02258391","volume":"40","author":"K Lundqvist","year":"1997","unstructured":"Lundqvist K, Broome U. Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study. Dis Colon Rectum. 1997;40(4):451\u20136.","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"620_CR56","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1440-1746.2005.03727.x","volume":"20","author":"A Moayyeri","year":"2005","unstructured":"Moayyeri A, Daryani NE, Bahrami H, Haghpanah B, Nayyer-Habibi A, Sadatsafavi M. Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis. J Gastroenterol Hepatol. 2005;20(3):366\u201370.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"620_CR57","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/gut.2004.046615","volume":"54","author":"EV Loftus Jr","year":"2005","unstructured":"Loftus EV Jr, Harewood GC, Loftus CG, Tremaine WJ, Harmsen WS, Zinsmeister AR, et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut. 2005;54(1):91\u20136. \n                      https:\/\/doi.org\/10.1136\/gut.2004.046615\n                      \n                    .","journal-title":"Gut"},{"issue":"22","key":"620_CR58","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.3748\/wjg.14.3497","volume":"14","author":"H Sokol","year":"2008","unstructured":"Sokol H, Cosnes J, Chazouilleres O, Beaugerie L, Tiret E, Poupon R, et al. Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis. World J Gastroenterol: WJG. 2008;14(22):3497\u2013503.","journal-title":"World J Gastroenterol: WJG"},{"issue":"6","key":"620_CR59","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1097\/PAS.0b013e318196d018","volume":"33","author":"M Joo","year":"2009","unstructured":"Joo M, Abreu-e-Lima P, Farraye F, Smith T, Swaroop P, Gardner L, et al. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study. Am J Surg Pathol. 2009;33(6):854\u201362. \n                      https:\/\/doi.org\/10.1097\/PAS.0b013e318196d018\n                      \n                    .","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"620_CR60","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s00534-010-0319-8","volume":"18","author":"H Sano","year":"2011","unstructured":"Sano H, Nakazawa T, Ando T, Hayashi K, Naitoh I, Okumura F, et al. Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis. J Hepatobiliary Pancreat Sci. 2011;18(2):154\u201361. \n                      https:\/\/doi.org\/10.1007\/s00534-010-0319-8\n                      \n                    .","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"9","key":"620_CR61","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/ibd.21569","volume":"17","author":"BD Ye","year":"2011","unstructured":"Ye BD, Yang SK, Boo SJ, Cho YK, Yang DH, Yoon SM, et al. Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea. Inflamm Bowel Dis. 2011;17(9):1901\u20136. \n                      https:\/\/doi.org\/10.1002\/ibd.21569\n                      \n                    .","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"620_CR62","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.crohns.2011.07.015","volume":"6","author":"JS Halliday","year":"2012","unstructured":"Halliday JS, Djordjevic J, Lust M, Culver EL, Braden B, Travis SP, et al. A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn\u2019s disease. J Crohns Colitis. 2012;6(2):174\u201381. \n                      https:\/\/doi.org\/10.1016\/j.crohns.2011.07.015\n                      \n                    .","journal-title":"J Crohns Colitis"},{"issue":"3","key":"620_CR63","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/ibd.21699","volume":"18","author":"KK Jorgensen","year":"2012","unstructured":"Jorgensen KK, Grzyb K, Lundin KE, Clausen OP, Aamodt G, Schrumpf E, et al. Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients. Inflamm Bowel Dis. 2012;18(3):536\u201345. \n                      https:\/\/doi.org\/10.1002\/ibd.21699\n                      \n                    .","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"620_CR64","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.cgh.2011.11.010","volume":"10","author":"A O'Toole","year":"2012","unstructured":"O'Toole A, Alakkari A, Keegan D, Doherty G, Mulcahy H, O'Donoghue D. Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2012;10(4):439\u201341. \n                      https:\/\/doi.org\/10.1016\/j.cgh.2011.11.010\n                      \n                    .","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"620_CR65","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1002\/ibd.22938","volume":"18","author":"K Boonstra","year":"2012","unstructured":"Boonstra K, van Erpecum KJ, van Nieuwkerk KM, Drenth JP, Poen AC, Witteman BJ, et al. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease. Inflamm Bowel Dis. 2012;18(12):2270\u20136. \n                      https:\/\/doi.org\/10.1002\/ibd.22938\n                      \n                    .","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"620_CR66","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1007\/s10620-013-2697-7","volume":"58","author":"DF Schaeffer","year":"2013","unstructured":"Schaeffer DF, Win LL, Hafezi-Bakhtiari S, Cino M, Hirschfield GM, El-Zimaity H. The phenotypic expression of inflammatory bowel disease in patients with primary sclerosing cholangitis differs in the distribution of colitis. Dig Dis Sci. 2013;58(9):2608\u201314. \n                      https:\/\/doi.org\/10.1007\/s10620-013-2697-7\n                      \n                    .","journal-title":"Dig Dis Sci"},{"issue":"5","key":"620_CR67","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1097\/MIB.0b013e3182802893","volume":"19","author":"E Sinakos","year":"2013","unstructured":"Sinakos E, Samuel S, Enders F, Loftus EV Jr, Sandborn WJ, Lindor KD. Inflammatory bowel disease in primary sclerosing cholangitis: a robust yet changing relationship. Inflamm Bowel Dis. 2013;19(5):1004\u20139. \n                      https:\/\/doi.org\/10.1097\/MIB.0b013e3182802893\n                      \n                    .","journal-title":"Inflamm Bowel Dis"},{"key":"620_CR68","doi-asserted-by":"publisher","unstructured":"Sorensen JO, Nielsen OH, Andersson M, Ainsworth MA, Ytting H, Belard E, et al. Inflammatory bowel disease with primary sclerosing cholangitis: a Danish population-based cohort study 1977-2011. Liver Int. 2017; \n                      https:\/\/doi.org\/10.1111\/liv.13548\n                      \n                    .","DOI":"10.1111\/liv.13548"},{"key":"620_CR69","doi-asserted-by":"publisher","unstructured":"\u2022 Cleveland NK, Rubin DT, Hart J, Weber CR, Meckel K, Tran AL, et al. Patients with ulcerative colitis and primary sclerosing cholangitis frequently have subclinical inflammation in the proximal colon. Clin Gastroenterol Hepatol. 2017; \n                      https:\/\/doi.org\/10.1016\/j.cgh.2017.07.023\n                      \n                    . Found that adult UC patients in clinical remission with PSC were more likely than those without PSC to have ongoing endoscopic and histologic disease in the right colon.","DOI":"10.1016\/j.cgh.2017.07.023"},{"issue":"12","key":"620_CR70","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.cgh.2012.07.008","volume":"10","author":"ME Feurer","year":"2012","unstructured":"Feurer ME, Hilden K, Adler DG. Primary sclerosing cholangitis and distribution of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2012;10(12):1418; author reply \u22129. \n                      https:\/\/doi.org\/10.1016\/j.cgh.2012.07.008\n                      \n                    .","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"620_CR71","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3109\/00365529709025107","volume":"32","author":"HH Rasmussen","year":"1997","unstructured":"Rasmussen HH, Fallingborg JF, Mortensen PB, Vyberg M, Tage-Jensen U, Rasmussen SN. Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn\u2019s disease. Scand J Gastroenterol. 1997;32(6):604\u201310.","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"620_CR72","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/ecco-jcc\/jju013","volume":"9","author":"H Yanai","year":"2015","unstructured":"Yanai H, Matalon S, Rosenblatt A, Awadie H, Berdichevski T, Snir Y, et al. Prognosis of primary sclerosing cholangitis in israel is independent of coexisting inflammatory bowel disease. J Crohns Colitis. 2015;9(2):177\u201384. \n                      https:\/\/doi.org\/10.1093\/ecco-jcc\/jju013\n                      \n                    .","journal-title":"J Crohns Colitis."},{"issue":"4","key":"620_CR73","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/meg.0000000000000576","volume":"28","author":"HH Zheng","year":"2016","unstructured":"\u2022 Zheng HH, Jiang XL. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies. Eur J Gastroenterol Hepatol. 2016;28(4):383\u201390. \n                      https:\/\/doi.org\/10.1097\/meg.0000000000000576\n                      \n                    . This large meta-analysis demonstrated that PSC-UC patients have a threefold higher risk of colorectal dysplasia and cancer than UC patients without PSC.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"620_CR74","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3109\/00365521.2014.907824","volume":"49","author":"A O'Toole","year":"2014","unstructured":"O'Toole A, Walsh P, Keegan D, Byrne K, Doherty G, O'Donoghue D, et al. Mortality in inflammatory bowel disease patients under 65 years of age. Scand J Gastroenterol. 2014;49(7):814\u20139. \n                      https:\/\/doi.org\/10.3109\/00365521.2014.907824\n                      \n                    .","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"620_CR75","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/00005176-200109000-00013","volume":"33","author":"WA Faubion Jr","year":"2001","unstructured":"Faubion WA Jr, Loftus EV, Sandborn WJ, Freese DK, Perrault J. Pediatric \u201cPSC-IBD\u201d: a descriptive report of associated inflammatory bowel disease among pediatric patients with psc. J Pediatr Gastroenterol Nutr. 2001;33(3):296\u2013300.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10","key":"620_CR76","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/ibd.22864","volume":"18","author":"F Ordonez","year":"2012","unstructured":"Ordonez F, Lacaille F, Canioni D, Talbotec C, Fournet JC, Cerf-Bensussan N, et al. Pediatric ulcerative colitis associated with autoimmune diseases: a distinct form of inflammatory bowel disease? Inflamm Bowel Dis. 2012;18(10):1809\u201317. \n                      https:\/\/doi.org\/10.1002\/ibd.22864\n                      \n                    .","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"620_CR77","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/MIB.0000000000000586","volume":"22","author":"L Lascurain","year":"2016","unstructured":"Lascurain L, Jensen MK, Guthery SL, Holmen J, Deneau M. Inflammatory bowel disease phenotype in pediatric primary sclerosing cholangitis. Inflamm Bowel Dis. 2016;22(1):146\u201350. \n                      https:\/\/doi.org\/10.1097\/MIB.0000000000000586\n                      \n                    .","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"620_CR78","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/MPG.0000000000001531","volume":"65","author":"H Shiau","year":"2017","unstructured":"Shiau H, Ihekweazu FD, Amin M, Fofanova T, Miloh T, Kellermayer R. Unique inflammatory bowel disease phenotype of pediatric primary sclerosing cholangitis: a single-center study. J Pediatr Gastroenterol Nutr. 2017;65(4):404\u20139. \n                      https:\/\/doi.org\/10.1097\/mpg.0000000000001531\n                      \n                    .","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"620_CR79","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1365-2036.2011.04753.x","volume":"34","author":"J Torres","year":"2011","unstructured":"Torres J, Pineton de Chambrun G, Itzkowitz S, Sachar DB, Colombel JF. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease. Aliment Pharmacol Ther. 2011;34(5):497\u2013508. \n                      https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04753.x\n                      \n                    .","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"620_CR80","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.mrrev.2004.08.001","volume":"589","author":"H Bernstein","year":"2005","unstructured":"Bernstein H, Bernstein C, Payne CM, Dvorakova K, Garewal H. Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res. 2005;589(1):47\u201365. \n                      https:\/\/doi.org\/10.1016\/j.mrrev.2004.08.001\n                      \n                    .","journal-title":"Mutat Res"},{"issue":"2","key":"620_CR81","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/MIB.0b013e318286ff2e","volume":"19","author":"J Torres","year":"2013","unstructured":"Torres J, Bao X, Iuga AC, Chen A, Harpaz N, Ullman T, et al. Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia. Inflamm Bowel Dis. 2013;19(2):275\u201382. \n                      https:\/\/doi.org\/10.1097\/MIB.0b013e318286ff2e\n                      \n                    .","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"620_CR82","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.cgh.2013.06.023","volume":"11","author":"DT Rubin","year":"2013","unstructured":"Rubin DT, Huo D, Kinnucan JA, Sedrak MS, McCullom NE, Bunnag AP, et al. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study. Clin Gastroenterol Hepatol. 2013;11(12):1601\u20138.e1\u20134. \n                      https:\/\/doi.org\/10.1016\/j.cgh.2013.06.023\n                      \n                    .","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"620_CR83","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1053\/j.gastro.2003.11.010","volume":"126","author":"M Rutter","year":"2004","unstructured":"Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126(2):451\u20139.","journal-title":"Gastroenterology"},{"issue":"supplement 2","key":"620_CR84","first-page":"S104","volume":"65","author":"A Ricciuto","year":"2017","unstructured":"\u2022 Ricciuto A, Carman N, Fish J, Crowley E, Church PC, Muise A, et al. 234 symptoms underestimate endoscopic activity in PSC-IBD. J Pediatr Gastroenterol Nutr. 2017;65(supplement 2):S104. Found that children with colitis in clinical remission with PSC are more likely than children without PSC to have ongoing endoscopic and histologic inflammation throughout the colon.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"620_CR85","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cgh.2012.12.027","volume":"11","author":"KK Jorgensen","year":"2013","unstructured":"Jorgensen KK, Lindstrom L, Cvancarova M, Karlsen TH, Castedal M, Friman S, et al. Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2013;11(5):517\u201323. \n                      https:\/\/doi.org\/10.1016\/j.cgh.2012.12.027\n                      \n                    .","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"620_CR86","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1097\/MIB.0000000000001105","volume":"23","author":"MR Fattahi","year":"2017","unstructured":"Fattahi MR, Malek-Hosseini SA, Sivandzadeh GR, Safarpour AR, Bagheri Lankarani K, Taghavi AR, et al. Clinical course of ulcerative colitis after liver transplantation in patients with concomitant primary sclerosing cholangitis and ulcerative colitis. Inflamm Bowel Dis. 2017;23(7):1160\u20137. \n                      https:\/\/doi.org\/10.1097\/mib.0000000000001105\n                      \n                    .","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"620_CR87","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1038\/ajg.2013.163","volume":"108","author":"S Singh","year":"2013","unstructured":"Singh S, Loftus EV Jr, Talwalkar JA. Inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Am J Gastroenterol. 2013;108(9):1417\u201325. \n                      https:\/\/doi.org\/10.1038\/ajg.2013.163\n                      \n                    .","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"620_CR88","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1053\/jhep.2002.30695","volume":"35","author":"I Dvorchik","year":"2002","unstructured":"Dvorchik I, Subotin M, Demetris AJ, Fung JJ, Starzl TE, Wieand S, et al. Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology (Baltimore, Md). 2002;35(2):380\u20134. \n                      https:\/\/doi.org\/10.1053\/jhep.2002.30695\n                      \n                    .","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"8\u20139","key":"620_CR89","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3109\/00365521.2012.685754","volume":"47","author":"KK Jorgensen","year":"2012","unstructured":"Jorgensen KK, Lindstrom L, Cvancarova M, Castedal M, Friman S, Schrumpf E, et al. Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study. Scand J Gastroenterol. 2012;47(8\u20139):1021\u20139. \n                      https:\/\/doi.org\/10.3109\/00365521.2012.685754\n                      \n                    .","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"620_CR90","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1111\/j.1600-6143.2006.01333.x","volume":"6","author":"RC Verdonk","year":"2006","unstructured":"Verdonk RC, Dijkstra G, Haagsma EB, Shostrom VK, Van den Berg AP, Kleibeuker JH, et al. Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2006;6(6):1422\u20139. \n                      https:\/\/doi.org\/10.1111\/j.1600-6143.2006.01333.x\n                      \n                    .","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"9","key":"620_CR91","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/j.1365-2036.2012.05067.x","volume":"35","author":"U Navaneethan","year":"2012","unstructured":"Navaneethan U, Choudhary M, Venkatesh PG, Lashner BA, Remzi FH, Shen B, et al. The effects of liver transplantation on the clinical course of colitis in ulcerative colitis patients with primary sclerosing cholangitis. Aliment Pharmacol Ther. 2012;35(9):1054\u201363. \n                      https:\/\/doi.org\/10.1111\/j.1365-2036.2012.05067.x\n                      \n                    .","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"620_CR92","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1046\/j.1365-2036.2003.01613.x","volume":"18","author":"EB Haagsma","year":"2003","unstructured":"Haagsma EB, Van Den Berg AP, Kleibeuker JH, Slooff MJ, Dijkstra G. Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens. Aliment Pharmacol Ther. 2003;18(1):33\u201344.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"620_CR93","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1478-3231.2011.02677.x","volume":"33","author":"D Joshi","year":"2013","unstructured":"Joshi D, Bjarnason I, Belgaumkar A, O'Grady J, Suddle A, Heneghan MA, et al. The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis. Liver Int. 2013;33(1):53\u201361. \n                      https:\/\/doi.org\/10.1111\/j.1478-3231.2011.02677.x\n                      \n                    .","journal-title":"Liver Int"},{"issue":"9","key":"620_CR94","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/j.1365-2036.2012.05063.x","volume":"35","author":"U Navaneethan","year":"2012","unstructured":"Navaneethan U, Venkatesh PG, Lashner BA, Shen B, Kiran RP. The impact of ulcerative colitis on the long-term outcome of patients with primary sclerosing cholangitis. Aliment Pharmacol Ther. 2012;35(9):1045\u201353. \n                      https:\/\/doi.org\/10.1111\/j.1365-2036.2012.05063.x\n                      \n                    .","journal-title":"Aliment Pharmacol Ther"},{"issue":"5, Supplement 1","key":"620_CR95","doi-asserted-by":"publisher","first-page":"S1057","DOI":"10.1016\/S0016-5085(17)33571-0","volume":"152","author":"A Ricciuto","year":"2017","unstructured":"Ricciuto A, Kamath BM, Abdou R, Alqoaer K, Amin M, Amir AZ, et al. 423\u2014a comparison of primary sclerosing cholangitis with and without associated inflammatory bowel disease: data from the Pediatric PSC Consortium. Gastroenterology. 2017;152(5, Supplement 1):S1057. \n                      https:\/\/doi.org\/10.1016\/S0016-5085(17)33571-0\n                      \n                    .","journal-title":"Gastroenterology"},{"issue":"5","key":"620_CR96","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/MEG.0000000000000596","volume":"28","author":"I Franceschet","year":"2016","unstructured":"Franceschet I, Cazzagon N, Del Ross T, D'Inca R, Buja A, Floreani A. Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options. Eur J Gastroenterol Hepatol. 2016;28(5):508\u201313. \n                      https:\/\/doi.org\/10.1097\/meg.0000000000000596\n                      \n                    .","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"620_CR97","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/apt.13516","volume":"43","author":"J Fevery","year":"2016","unstructured":"\u2022 Fevery J, Van Steenbergen W, Van Pelt J, Laleman W, Hoffman I, Geboes K, et al. Patients with large-duct primary sclerosing cholangitis and Crohn\u2019s disease have a better outcome than those with ulcerative colitis, or without IBD. Aliment Pharmacol Ther. 2016;43(5):612\u201320. \n                      https:\/\/doi.org\/10.1111\/apt.13516\n                      \n                    . Demonstrated that the improved PSC outcomes in PSC-CD are independent of its association with small duct disease.","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"620_CR98","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.cgh.2011.08.027","volume":"9","author":"JH Ngu","year":"2011","unstructured":"Ngu JH, Gearry RB, Wright AJ, Stedman CA. Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol. 2011;9(12):1092\u20137; quiz e135. \n                      https:\/\/doi.org\/10.1016\/j.cgh.2011.08.027\n                      \n                    .","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"620_CR99","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1055\/s-0037-1608655","volume":"37","author":"EF Martin","year":"2017","unstructured":"Martin EF, Levy C. Timing, management, and outcomes of liver transplantation in primary sclerosing cholangitis. Semin Liver Dis. 2017;37(4):305\u201313. \n                      https:\/\/doi.org\/10.1055\/s-0037-1608655\n                      \n                    .","journal-title":"Semin Liver Dis"},{"key":"620_CR100","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Lindstrom L, Jorgensen KK, Boberg KM, Castedal M, Rasmussen A, Rostved AA, et al. Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic multicentre study. Scand J Gastroenterol. 2018:1\u20138. \n                      https:\/\/doi.org\/10.1080\/00365521.2017.1421705\n                      \n                    . Observed a significantly decreased risk of recurrent PSC after liver transplantation with colectomy pre- or peri-transplant.","DOI":"10.1080\/00365521.2017.1421705"},{"key":"620_CR101","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Ravikumar R, Tsochatzis E, Jose S, Allison M, Athale A, Creamer F, et al. Risk factors for recurrent primary sclerosing cholangitis after liver transplantation. J Hepatol. 2015; \n                      https:\/\/doi.org\/10.1016\/j.jhep.2015.07.005\n                      \n                    . Found ulcerative colitis post-liver transplant (vs no UC or colectomy before transplant) to be a risk factor for recurrent PSC after transplantation.","DOI":"10.1016\/j.jhep.2015.07.005"},{"issue":"3","key":"620_CR102","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/lt.21679","volume":"15","author":"E Alabraba","year":"2009","unstructured":"Alabraba E, Nightingale P, Gunson B, Hubscher S, Olliff S, Mirza D, et al. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Liver Transpl. 2009;15(3):330\u201340. \n                      https:\/\/doi.org\/10.1002\/lt.21679\n                      \n                    .","journal-title":"Liver Transpl"},{"issue":"9349","key":"620_CR103","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/S0140-6736(02)11861-7","volume":"360","author":"A Vera","year":"2002","unstructured":"Vera A, Moledina S, Gunson B, Hubscher S, Mirza D, Olliff S, et al. Risk factors for recurrence of primary sclerosing cholangitis of liver allograft. Lancet. 2002;360(9349):1943\u20134. \n                      https:\/\/doi.org\/10.1016\/s0140-6736(02)11861-7\n                      \n                    .","journal-title":"Lancet"},{"issue":"2","key":"620_CR104","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/lt.21260","volume":"14","author":"E Cholongitas","year":"2008","unstructured":"Cholongitas E, Shusang V, Papatheodoridis GV, Marelli L, Manousou P, Rolando N, et al. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl. 2008;14(2):138\u201343. \n                      https:\/\/doi.org\/10.1002\/lt.21260\n                      \n                    .","journal-title":"Liver Transpl"},{"key":"620_CR105","doi-asserted-by":"publisher","unstructured":"Nordenvall C, Ol\u00e9n O, Nilsson PJ, von Seth E, Ekbom A, Bottai M et al. Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study of 2594 PSC-IBD patients. Aliment. Pharmacol. Ther. 2018;47(2):238\u201345. \n                      https:\/\/doi.org\/10.1111\/apt.14393\n                      \n                    .","DOI":"10.1111\/apt.14393"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-018-0620-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-018-0620-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-018-0620-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T20:44:04Z","timestamp":1553719444000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-018-0620-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,28]]},"references-count":105,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["620"],"URL":"https:\/\/doi.org\/10.1007\/s11894-018-0620-2","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,28]]},"assertion":[{"value":"28 March 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"16"}}